These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1217 related items for PubMed ID: 20357160

  • 1. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A, Ho J, Wong J, Yin L, Chung F.
    Anesth Analg; 2010 Apr 01; 110(4):1239. PubMed ID: 20357160
    [Abstract] [Full Text] [Related]

  • 2. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A, Ho J, Wong J, Yin L, Chung F.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007362. PubMed ID: 19821409
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM, Duch P, Allingstrup M, Afshari A.
    Cochrane Database Syst Rev; 2017 Aug 14; 8(8):CD012763. PubMed ID: 28806470
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M.
    Anesthesiology; 2007 Aug 14; 107(2):239-44. PubMed ID: 17667567
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS.
    Anesthesiology; 2008 Aug 14; 109(2):188-97. PubMed ID: 18648227
    [Abstract] [Full Text] [Related]

  • 8. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O, White PF, Tufanogullari B, Klein K.
    Anesth Analg; 2007 Mar 14; 104(3):569-74. PubMed ID: 17312210
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M, Zarantonello F, Tellaroli P, Ori C.
    J Clin Anesth; 2016 Dec 14; 35():1-12. PubMed ID: 27871504
    [Abstract] [Full Text] [Related]

  • 10. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, Hudson ME.
    Anesth Analg; 2009 Mar 14; 108(3):846-51. PubMed ID: 19224792
    [Abstract] [Full Text] [Related]

  • 11. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G, Pompei L.
    Minerva Anestesiol; 2009 May 14; 75(5):349-51. PubMed ID: 19412157
    [Abstract] [Full Text] [Related]

  • 12. Neuromuscular transmission: new concepts and agents.
    de Boer HD.
    J Crit Care; 2009 Mar 14; 24(1):36-42. PubMed ID: 19272537
    [Abstract] [Full Text] [Related]

  • 13. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME.
    Eur J Anaesthesiol; 2010 Oct 14; 27(10):874-81. PubMed ID: 20683334
    [Abstract] [Full Text] [Related]

  • 14. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D, Paulden M, Paton F, Heirs M, Duffy S, Craig D, Hunter J, Wilson J, Sculpher M, Woolacott N.
    Health Technol Assess; 2010 Jul 14; 14(39):1-211. PubMed ID: 20688009
    [Abstract] [Full Text] [Related]

  • 15. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G, Niskanen M, Laurila P, Mizikov V, Hübler M, Beck G, Rietbergen H, Nicolayenko E.
    Anaesthesia; 2012 Sep 14; 67(9):991-8. PubMed ID: 22698066
    [Abstract] [Full Text] [Related]

  • 16. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P, Kuizenga K, Saldien V, Claudius C, Servin F, Klein J, Debaene B, Heeringa M.
    Anesth Analg; 2010 Jan 01; 110(1):74-82. PubMed ID: 19933538
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
    Ploeger BA, Smeets J, Strougo A, Drenth HJ, Ruigt G, Houwing N, Danhof M.
    Anesthesiology; 2009 Jan 01; 110(1):95-105. PubMed ID: 19104176
    [Abstract] [Full Text] [Related]

  • 18. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME.
    Br J Anaesth; 2008 May 01; 100(5):622-30. PubMed ID: 18385265
    [Abstract] [Full Text] [Related]

  • 19. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM.
    Anesthesiology; 2007 May 01; 106(5):935-43. PubMed ID: 17457124
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.